期刊
CURRENT OPINION IN BIOTECHNOLOGY
卷 20, 期 5, 页码 516-521出版社
CURRENT BIOLOGY LTD
DOI: 10.1016/j.copbio.2009.09.005
关键词
-
资金
- MRC Centre for Regenerative Medicine
- Canadian Stem Cell Network
- MRC
- MRC [G0700672] Funding Source: UKRI
- Medical Research Council [G0700711B, G0700672] Funding Source: researchfish
Direct reprogramming of somatic cells to a pluripotent state, substantiated only three years prior, is one of the most rapidly developing areas of stem cell research. The generation of patient-derived pluripotent cells applicable to disease modelling, drug screening, toxicology tests and, ultimately, autologous cell-based therapies, has the potential to revolutionize medicine. Since 2006, when Takahashi and Yamanaka first reported the generation of induced pluripotent stem cells from murine fibroblasts via retroviral transduction of a defined set of transcription factors, various new methods have been developed to refine and improve reprogramming technology. This review focusses on these evolving strategies to generate genetically unmodified or reprogramming factor-free iPSCs.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据